Alerts will be sent to your verified email
Verify EmailAMRUTANJAN
Amrutanjan Healthcar
|
TTK Healthcare
|
Nureca Ltd.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.33 % | 0.18 % | n/a |
Financials
|
|||
5 yr Average ROE
|
14.67 % | 22.02 % | 33.5 % |
5yr average Equity Multiplier
|
1.41 | 1.58 | 1.74 |
5yr Average Asset Turnover Ratio
|
1.22 | 1.15 | 1.65 |
5yr Avg Net Profit Margin
|
8.57 % | 22.14 % | 9.68 % |
Price to Book
|
8.56 | 2.2 | 1.45 |
P/E
|
50.94 | 32.98 | 346.6 |
5yr Avg Cash Conversion Cycle
|
21.59 Days | -41.8 Days | 140.67 Days |
Inventory Days
|
23.18 Days | 41.67 Days | 73.5 Days |
Days Receivable
|
51.48 Days | 36.67 Days | 11.25 Days |
Days Payable
|
49.13 Days | 102.9 Days | 36.21 Days |
5yr Average Interest Coverage Ratio
|
27.21 | 11.04 | 29.97 |
5yr Avg ROCE
|
24.07 % | 9.07 % | 42.4 % |
5yr Avg Operating Profit Margin
|
17.1 % | 7.68 % | 14.47 % |
5 yr average Debt to Equity
|
0.12 | 0.07 | 0.14 |
5yr CAGR Net Profit
|
16.38 % | 92.23 % | n/a |
5yr Average Return on Assets
|
10.59 % | 16.15 % | 16.71 % |
Shareholdings
|
|||
Promoter Holding
|
50.59 % | 74.56 % | 63.24 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.57 % | 0.0 | -6.76 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.55 % | -2.29 % | -1.63 % |
Amrutanjan Healthcar
|
TTK Healthcare
|
Nureca Ltd.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|